STATE OF THE ART PAPER
Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions
 
More details
Hide details
1
University Medical Center Groningen, Department of Pathology and Medical Biology, Netherlands
2
Institute of Clinical Biochemistry, Hannover Medical School, Germany
3
Department of Biomedical Sciences, University of Copenhagen, Denmark
Submission date: 2019-08-14
Final revision date: 2019-09-13
Acceptance date: 2019-10-23
Online publication date: 2020-01-31
 
 
KEYWORDS
TOPICS
ABSTRACT
The immune system is frequently described in the context of its protective function against infections and its role in the development of autoimmunity. For more than a decade, the interactions between the immune system and metabolic processes have been reported, in effect creating a new research field, termed immunometabolism. Accumulating evidence supports the hypo¬thesis that the development of metabolic diseases may be linked to inflammation, and reflects, in some cases, the activation of immune responses. As such, immunometabolism is defined by 1) inflammation as a driver of disease development and/or 2) metabolic processes stimulating cellular differentiation of the immune components. In this review, the main factors capable of altering the immuno-metabolic communication leading to the development and establishment of obesity and diabetes are comprehensively presented. Tissue-specific immune responses suggested to impair metabolic processes are described, with an emphasis on the adipose tissue, gut, muscle, liver, and pancreas.
eISSN:1896-9151
ISSN:1734-1922